Your browser doesn't support javascript.
loading
Precision, complexity and stigma in advanced prostate cancer terminology: it is time to move away from 'castration-resistant' prostate cancer.
Pezaro, C J; Omlin, A; Mastris, K; Attard, G; Beer, T M; Chi, K N; Chowdhury, S; Davis, I D; Drake, C G; de Bono, J S; Efstathiou, E; Gravis, G; Higano, C S; Hussain, M; James, N; Logothetis, C J; Morgans, A; Parker, C; Ryan, C J; Saad, F; Sartor, O; Small, E J; Sternberg, C N; Sweeney, C J; Tannock, I; Tombal, B; Gillessen, S.
Affiliation
  • Pezaro CJ; Eastern Health & Monash University, Melbourne, Australia.
  • Omlin A; Department of Oncology and Haematology, Cantonal Hospital St. Gallen, St. Gallen, Switzerland and University of Bern, Switzerland.
  • Mastris K; Europa Uomo Prostate Patients, Clayhall Ilford, UK.
  • Attard G; The Institute of Cancer Research/Royal Marsden NHS Foundation Trust, London, UK.
  • Beer TM; Knight Cancer Institute, Oregon Health & Science University, Portland, USA.
  • Chi KN; BC Cancer Agency and University of British Columbia, Vancouver, Canada.
  • Chowdhury S; Department of Medical Oncology, Guy's Hospital, London, UK.
  • Davis ID; Monash University Eastern Health Clinical School, Melbourne, Australia.
  • Drake CG; Division of Haematology/Oncology, Columbia University Medical Center, New York.
  • de Bono JS; The Institute of Cancer Research/Royal Marsden NHS Foundation Trust, London, UK.
  • Efstathiou E; Department of Genitourinary Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, USA.
  • Gravis G; Department of Cancer Medicine, Institut Paoli Calmette, Marseille, France.
  • Higano CS; Fred Hutchinson Cancer Research Center, University of Washington, Seattle.
  • Hussain M; Robert H Lurie Comprehensive Cancer Center, Northwestern University Feinberg School of Medicine, Chicago, USA.
  • James N; Clinical Oncology Unit, Queen Elizabeth Hospital Birmingham, University of Birmingham, Birmingham, UK.
  • Logothetis CJ; Department of Genitourinary Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, USA.
  • Morgans A; Department of Clinical Therapeutics, David H. Koch Centre, Alexandra Hospital, University of Athens, Athens, Greece.
  • Parker C; Division of Hematology/Oncology, Vanderbilt University Medical Center, Nashville, USA.
  • Ryan CJ; Clinical Oncology Academic Unit, Royal Marsden NHS Foundation Trust, London, UK.
  • Saad F; Clinical Medicine and Urology at the Helen Diller Family Comprehensive Cancer Center at the University of California, San Francisco (UCSF), San Francisco, USA.
  • Sartor O; Department of Surgery, Centre Hospitalier de Université de Montréal, Montreal, Canada.
  • Small EJ; Department of Medicine and Urology, Tulane Cancer Center, New Orleans.
  • Sternberg CN; Department of Medicine, University of California, San Francisco, USA.
  • Sweeney CJ; Department of Medical Oncology, San Camillo Forlanini Hospital, Rome, Italy.
  • Tannock I; Department of Medical Oncology, Dana-Farber Cancer Institute and Brigham and Women's Hospital, Harvard Medical School, Boston, USA.
  • Tombal B; Division of Medical Oncology, Princess Margaret Cancer Centre, Toronto, Canada.
  • Gillessen S; Cliniques Universitaires Saint Luc, Brussels, Belgium.
Ann Oncol ; 28(8): 1692-1694, 2017 08 01.
Article in En | MEDLINE | ID: mdl-28838209
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Prostatic Neoplasms, Castration-Resistant Type of study: Diagnostic_studies Limits: Humans / Male Language: En Journal: Ann Oncol Journal subject: NEOPLASIAS Year: 2017 Document type: Article Affiliation country:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Prostatic Neoplasms, Castration-Resistant Type of study: Diagnostic_studies Limits: Humans / Male Language: En Journal: Ann Oncol Journal subject: NEOPLASIAS Year: 2017 Document type: Article Affiliation country: